Dr.ci:labo Brand Ranking

Dr.Ci:Labo

Industry： Toner , Freckle removal skin care products , Medicinal makeup , Astringent and softening skin , Sunscreen , Oil control toner , Moisturizing lotion

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Dr.Ci:Labo

Industry： Toner , Freckle removal skin care products , Medicinal makeup , Astringent and softening skin , Sunscreen , Oil control toner , Moisturizing lotion

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Brand Introduction

Dr.Ci:Labo Dr. Chengo was founded in Japan in February 1999 by Dr. Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Chengo Cheng The brand started with mail order and opened the market with the multi-function 5-in-1 Aqua-Collagen-Gel marine collagen hydrogel series. The parent company is Co., Ltd., a listed company in Tokyo, with the English name Ci: z Holdings Co., Ltd.

Important Events

Founded Dr.Ci:Labo in 1999;

In 2000, health nutritional supplements, beauty instruments, makeup, and body care products were launched;

Listed in Japan in 2002;

In 2004, it landed in the Hong Kong Special Administrative Region, Taiwan Province, Hawaii and other places;

In July 2016, Cilag GmbH International, a subsidiary of Johnson & Johnson, acquired 19.9% of the equity of Ci:z Holdings, a manufacturer of Chengye Doctors, and became the second largest shareholder of Ci:z Holdings;

On October 23, 2018, Johnson & Johnson issued an announcement stating that it will acquire the remaining 80% of the shares of the Japanese cosmetics company Ci: z Holdings Co Ltd Group for 230 billion yen (about 2.05 billion US dollars). Johnson & Johnson launched a tender offer on October 29, hoping to The transaction was completed in the first half of 2019. After the acquisition is completed, Johnson & Johnson will own three major brands, Dr.Ci:Labo, Labo Labo and Genomer, a subsidiary of Ci:z Holdings.